These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15320834)

  • 1. Pharmacological modulations of the renin-angiotensin-aldosterone system in human congestive heart failure: effects on peripheral vascular endothelial function.
    Nakamura M
    Curr Vasc Pharmacol; 2004 Jan; 2(1):65-70. PubMed ID: 15320834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?
    Mielniczuk L; Stevenson LW
    Curr Opin Cardiol; 2005 Jul; 20(4):250-5. PubMed ID: 15956818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
    Kjaer A; Hesse B
    Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vasopressin in congestive heart failure.
    Goldsmith SR
    Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S19-23. PubMed ID: 16970149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
    Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
    J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention.
    Bernal J; Pitta SR; Thatai D
    Am J Cardiovasc Drugs; 2006; 6(6):373-81. PubMed ID: 17192127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
    Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J
    Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
    Partigulova AS; Naumov VG
    Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
    Radzevich AE; Ditiatkov AE; Tikhonov VA
    Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.
    Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C
    Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical potential of renin inhibitors and angiotensin antagonists.
    Cody RJ
    Drugs; 1994 Apr; 47(4):586-98. PubMed ID: 7516858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the renin angiotensin system: implications for the endothelium.
    Savoia C; Schiffrin EL
    Curr Diab Rep; 2006 Aug; 6(4):274-8. PubMed ID: 16879778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
    Weber MA
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.